Visfatin and Resveratrol Differentially Regulate the Expression of Thymidylate Synthase to Control the Sensitivity of Human Colorectal Cancer Cells to Capecitabine Cytotoxicity

Colorectal cancer (CRC) is a highly lethal malignant cancer. Capecitabine, a 5-fluororacil (5-FU) derivate, is its first-line drug, but the resistance of CRC to capecitabine is still the most challenging factor for curing patients. It has been suggested that thymidylate synthase (TYMS) level might a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Kuen-Lin, Lee, Ko-Chao, Yen, Chia-Kuang, Chen, Cheng-Nan, Chang, Shun-Fu, Huang, Wen-Shih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704879/
https://www.ncbi.nlm.nih.gov/pubmed/34947902
http://dx.doi.org/10.3390/life11121371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704879/
https://www.ncbi.nlm.nih.gov/pubmed/34947902
http://dx.doi.org/10.3390/life11121371

Ejemplares similares